Medical weight loss in Ash Flat, Arkansas
Semaglutide and tirzepatide injections, phentermine, and hormone therapy, supervised by Sarah Scheel, FNP-BC, in the same office you see for everything else. No telehealth middleman, no mail-order mystery pharmacy. Weekly check-ins, labs when they are needed, and someone who actually knows you.
Serving Ash Flat, Highland, Cherokee Village, Hardy, Horseshoe Bend, Salem and the Spring River area.
Programs
Weight loss visit, from $70
Semaglutide with B12 or tirzepatide with niacinamide, weekly injections, with check-ins to manage dose and side effects. Several options from $70; the medication sets the price. Book online, 15 minutes, and put your height and weight in the notes.
Weight loss by telehealth
Same program by video for established patients. Price depends on the medication and dose.
Phentermine 37.5 mg
Prescription appetite suppressant, covered under the weight loss visit. Prescriptions can only be filled in Arkansas.
Testosterone replacement, $150
Plus labs and medication. Managed by Sarah, labs drawn in the office before you start.
Women's hormone replacement, from $99
Pills, injections or patches for hot flashes, night sweats, sleep, mood and brain fog. In office or by telehealth; medication ships to your door.
Styku body scan, $60
A three-minute 3D scan that tracks fat, muscle and measurements, so progress is more than a number on the scale. Free for current patients once every three months.
Sermorelin peptide therapy
7.5 mL vial. See what to know about sermorelin below.
NAD+ injections
10 mL vial. See what to know about NAD+ below.
Medical skin care, from $120
Tretinoin, NAD+ cream and GHK-Cu serum for texture, fine lines and hair thinning. Prescribed at a 15 minute visit, shipped to your house.
Who qualifies for the weight loss program: a BMI over 30, or over 27 with a related condition such as high blood pressure or diabetes. Sarah confirms it at the first visit.
Book a weight loss visitHow to start
Book the weight loss visit online
Pick a 15 minute slot, put your height and weight in the notes, done. Or call 870-955-5058 and we will set it up.
Your first visit
Sarah goes over your history, weight, medications and goals, draws labs if they are needed, and tells you honestly which option fits and what it costs.
Weekly injections, regular check-ins
You leave with a plan. Follow-up visits are 15 minutes and you book them online, in person or by telehealth.
Weight loss questions
Short answers. Sarah covers the rest at your visit.
What is the difference between semaglutide and tirzepatide?
Both are weekly injections that work on the hormones that control appetite and blood sugar. Semaglutide is the medicine in Ozempic and Wegovy; tirzepatide is the medicine in Mounjaro and Zepbound. Sarah will tell you which one fits your history, and the cost difference, at your first visit.
Do I have to be a patient of the practice already?
No. Book the weight loss visit online as a new patient; it is a 15 minute appointment from $70. You qualify with a BMI over 30, or over 27 with a related condition. After that, your follow-ups book online too, in person or by telehealth.
What does it cost?
The visit is from $70 and the medication sets the rest, which Sarah goes over before anything is prescribed. We take insurance for visits; coverage for the medications themselves varies by plan, so bring your card.
Where is the medication filled?
Prescriptions are written to be filled in Arkansas. Phentermine in particular can only be filled in Arkansas.
How often do I come in?
Expect a first visit, then regular check-ins while the dose is being adjusted. Most people settle into short follow-ups that take about 15 minutes.
Who should not do this?
Anyone pregnant, breastfeeding or trying to conceive, and people with certain thyroid, pancreas or kidney history. That is exactly what the first visit and labs are for; Sarah will say no when the answer is no.
Can I add hormone therapy or peptides?
Testosterone and hormone replacement, sermorelin and NAD+ are all managed here by Sarah. They start with labs.
What to know about sermorelin and NAD+
Written by Sarah. These are wellness therapies, not FDA-approved treatments for aging or fatigue, and we say so up front.
Sermorelin
Sermorelin is a synthetic version of growth hormone releasing hormone (GHRH). It works by stimulating the pituitary gland to release the body's own growth hormone, which can in turn increase IGF-1 production. In appropriately selected patients, optimizing the growth hormone and IGF-1 pathway may be associated with changes in body composition, recovery, sleep, and overall well-being. These commonly promoted adult anti-aging or wellness benefits are not established FDA-approved indications for sermorelin. Treatment is individualized and monitored clinically, typically including IGF-1 and relevant metabolic labs.
Who should not use it
Sermorelin should generally be avoided during pregnancy or breastfeeding and in patients with active or suspected malignancy. Additional caution is appropriate in patients with diabetes or impaired glucose control, significant edema, untreated sleep apnea, or conditions in which increased GH/IGF-1 activity could pose a risk. Patients with pituitary or hypothalamic disease should have an appropriate evaluation first, because sermorelin requires adequate pituitary function to produce a growth hormone response.
NAD+
Nicotinamide adenine dinucleotide (NAD+) is a naturally occurring coenzyme involved in cellular energy metabolism, mitochondrial function, DNA repair, and many enzymatic reactions throughout the body. NAD+ availability changes with aging, which has generated interest in NAD+ therapy for energy, recovery, metabolic health, cognitive function, and healthy aging. Current human research does not yet establish that injectable NAD+ produces these benefits, and a 2026 systematic review found no eligible outcomes trials of IV, IM, or subcutaneous NAD+ for anti-aging or wellness. We present injectable NAD+ as an investigational wellness therapy, not a proven treatment for fatigue or aging.
Who should not use it
Patients who are pregnant or breastfeeding, have significant kidney or liver disease, active cancer, serious uncontrolled medical conditions, or a known allergy to the formulation should generally avoid treatment or get medical clearance first. Because safety data are still limited, we review your medication history and underlying conditions before treatment. The FDA has reported adverse reactions with compounded injectable NAD+, including severe chills, shaking, vomiting, and fatigue, which is why we only use appropriately sourced sterile compounded preparations.